Replimune Group, Inc.
Here’s whether Replimune Group, Inc. (REPL) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.45% over 10 days); 3-month momentum positive (+9.7%); rising volume confirms the move (1.25x 30d avg). Concerns: RSI 77 — overbought, elevated pullback risk. Currently 28.5% off its 52-week high. Score: +5/7.
REPL is in a confirmed uptrend, trading above both its 50-day ($4.96) and 200-day ($6.89) moving averages. With an RSI of 77.1, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -2.9% compares to +24.4% for SPY (trailed the market by 27.2%). The current 28.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.